Cargando…
Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran
HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a sui...
Autores principales: | Khatibi, Mohsen, Rasekh, Hamid Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403082/ https://www.ncbi.nlm.nih.gov/pubmed/25901173 |
Ejemplares similares
-
Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
por: Khatibi, Mohsen, et al.
Publicado: (2014) -
Cost-effectiveness of Varicella Vaccination Program in Iran
por: Esmaeeli, Shooka, et al.
Publicado: (2017) -
Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model
por: Viyanchi, Amir, et al.
Publicado: (2016) -
Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?
por: Salamzadeh, Jamshid, et al.
Publicado: (2014) -
Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
por: Rasekh, Hamid Reza, et al.
Publicado: (2011)